Merck KGaA

Merck KGaAMerck is a global pharmaceutical and chemical company with total revenues of EUR 7.7 billion in 2009, a history that began in 1668, and a future shaped by approximately 40,000 (including Merck Millipore) employees in 64 countries. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since. For more information, visit www.merck.de.

Merck KGaA RSS Channel

Title Filter      Display #  
# Article Title
1 Merck Serono enters into research agreement with Pfizer and Broad Institute
2 Merck Serono announces five-year strategic partnership with the Lead Discovery Center
3 Merck announces collaboration with nordic Bioscience for Sprifermin
4 Merck total revenues increase 3.2% to € 2.6 billion
5 Merck announces efficiency program across all businesses and regions
6 Merck Helps Eliminate Schistosomiasis in Africa
7 Merck Sends Assistance to Flood-Ravaged Thailand
8 Merck Total Revenues Increase by 4% to € 2.5 Billion
9 Merck and Ono Pharmaceutical Form Collaborations
10 Merck publishes innovation brochure with interactive features
11 Merck Total Revenues Increase by 16% to EUR 2.6 Billion
12 Merck: Regulatory Update on Cladribine Tablets
13 Merck and Its Employees to Donate to Japanese Relief Effort
14 Merck KGaA Acquires Supplier to Biopharma Industry in China
15 Merck KGaA and sanofi-aventis to Investigate Novel Combinations Against Cancer
16 Merck KGaA Donation Program Supports Schistosomiasis Control in Africa
17 Merck KGaA Announces Extension of FDA Priority Review Period for Cladribine Tablets
18 Merck KGaA Sells Théramex To Teva for EUR 265 million
19 Merck KGaA Profit After Tax Jumps 45% to EUR 215 Million
20 Merck KGaA to Introduce RebiDose, the Rebif Single Use Pre-filled Pen for Treatment of Multiple Sclerosis
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]